Multiple sclerosis: summary of NICE guidance

BMJ. 2014 Oct 8:349:g5701. doi: 10.1136/bmj.g5701.

Authors

Mark Perry¹, Sharon Swain², Sophia Kemmis-Betty², Paul Cooper³; Guideline Development Group of the National Institute for Health and Care Excellence

Collaborators

Guideline Development Group of the National Institute for Health and Care Excellence:
Lola Adedokun, Noreen Barker, Pamela Bostock, Peter Brex, Jeremy Chataway, Krishna Chinthapalli, Paul Cooper, Elisabetta Fenu, Sarah Gillanders, Aleks de Gromoboy, Lina Gulhane, Wendy Hendrie, Ann Hodgson, Susan Hourihan, Amy Kelsey, Sophia Kemmis-Betty, David Kernick, Kate Lovibond, Paul Riordan-Eva, Emma Rowe, Sharon Swain, Norma O'Flynn, Mark Perry, Richard Warner

Affiliations

¹ National Clinical Guideline Centre, Royal College of Physicians, London NW1 4LE, UK mark.perry@rcplondon.ac.uk.
² National Clinical Guideline Centre, Royal College of Physicians, London NW1 4LE, UK.
³ Neurology Department, Salford Royal Foundation Trust, Salford, UK Department of Medicine, University of Manchester, Manchester, UK.

PMID: 25298369
DOI: 10.1136/bmj.g5701

No abstract available

Publication types

Practice Guideline

MeSH terms

Humans
Multiple Sclerosis / diagnosis*
Multiple Sclerosis / therapy*